Smart pill can track key biological markers in real-time
Coupling engineered bacteria with low-power electronics could be highly effective in diagnosis, treatment of bowel diseases.
Researchers uncover a new CRISPR-like system in animals that can edit the human genome
The first RNA-guided DNA-cutting enzyme found in eukaryotes, Fanzor could one day be harnessed to edit DNA more precisely than CRISPR/Cas systems.
Inaugural J-WAFS Grand Challenge aims to develop enhanced crop variants and move them from lab to land
Matt Shoulders will lead an interdisciplinary team to improve RuBisCO — the photosynthesis enzyme thought to be the holy grail for improving agricultural yield.
3 Questions: Cullen Buie on a new era for cell therapies
The associate professor of MechE reflects on how his company, Kytopen, has grown and shifted focus in developing safer immunotherapies.
New leadership at MIT’s Center for Biomedical Innovation
Stacy Springs named executive director; Richard Braatz is associate faculty director.
New CRISPR-based map ties every human gene to its function
Jonathan Weissman and collaborators used their single-cell sequencing tool Perturb-seq on every expressed gene in the human genome, linking each to its job in the cell.
Convenience-sized RNA editing
MIT neuroscientists expand CRISPR toolkit with new, compact Cas7-11 enzyme.
RNA-targeting enzyme expands the CRISPR toolkit
Exploring diversity among bacterial immune systems, McGovern Institute scientists uncovere a programmable system for precisely targeting and modifying RNA.
New programmable gene editing proteins found outside of CRISPR systems
Researchers find RNA-guided enzymes are more diverse and widespread than previously believed.
A new technique for correcting disease-causing mutations
Novel method, developed by McGovern Institute researchers, may lead to safer, more efficient gene therapies.
An on-off switch for gene editing
New, reversible CRISPR method can control gene expression while leaving underlying DNA sequence unchanged.
New molecular therapeutics center established at MIT's McGovern Institute
Collaborative research center funded by Lisa Yang and Hock Tan ’75 blends engineering and neuroscience to advance molecular tools for treating brain disorders.
Making real a biotechnology dream: nitrogen-fixing cereal crops
Voigt Lab's work could eventually replace cereal crops’ need for nitrogen from chemical fertilizers.
Biotech startup uses nanoparticles to induce immune tolerance
Selecta Bioscience’s ImmTOR platform could improve gene therapies and prevent some drug side effects.
Keeping genetic engineering localized
Researchers are developing a so-called "daisy-chain" gene-drive system that provides controls for genetic engineering of certain populations.